Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Holbæk
Clinical trial register · Denmark

Clinical Trials in Holbæk, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Denmark and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2469 matching records held by the registry are in this view. Synced 16 Oct 2026, 03:17 UTC
2469
Studies in scope
all four open statuses
1395
Recruiting now
open to new participants
438
Lead sponsors
across recruiting studies
Top sites
Copenhagen 974 Aarhus 586 Odense 441 Aalborg 384 Herlev 314
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca5 Novo Nordisk A/S5 Copenhagen Respiratory Research2 Amgen2 Alnylam Pharmaceuticals1
Site location
Copenhagen974 Aarhus586 Odense441 Aalborg384 Herlev314
All 128 locations
Target enrolment
to

Trials with a site in Holbæk

36 of 2469 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Denmark
Start
Recruiting
AstraZeneca
Phase 3
500
Aarhus N, Gandrup, Herlev, Holbæk, Hvidovre, Middelfart, Odense, Vejle
2026-08-24
Recruiting
AstraZeneca
Phase 3
7,000
Aalborg, Aarhus, Copenhagen E, Herlev, Herning, Holbæk, Roskilde
2026-08-21
Not yet open
Effect of Testosterone on Elderly Frail Men With Testosterone Deficiency
NCT07512323Frail Elderly Patients, Hypogonadal Males, Testosterone Replacement Therapy, Falls (Accidents) in Old Age
DrugNebido
Rune Skovgaard Rasmussen
Phase 2
96
Holbæk
2026-08-01
Recruiting
AstraZeneca
Phase 3
900
Aarhus N, Gistrup, Herlev, Hillerød, Holbæk, Hvidovre
2026-07-06
Recruiting
Novo Nordisk A/S
Phase 3
5,610
Aabenraa, Frederiksberg, Herlev, Hjørring, Holbæk, Hvidovre, København Ø, Svendborg
2026-05-11
Recruiting
Copenhagen Respiratory Research
Phase 4
1,600
Rønne, Copenhagen, Frederiksberg, Hellerup, Herlev, Hvidovre, Hillerød, Holbæk
2026-03-10
Recruiting
Copenhagen Respiratory Research
Phase 4
2,000
Rønne, Copenhagen, Frederiksberg, Hellerup, Herlev, Hvidovre, Hillerød, Holbæk
2026-03-10
Recruiting
Novo Nordisk A/S
Phase 3
460
Aalborg, Holbæk
2026-01-08
Recruiting
Alnylam Pharmaceuticals
Phase 3
11,000
Esbjerg, Holbæk, Hvidovre, København S, Odense, Vejle
2025-09-06
Recruiting
Procedural Sedation and Analgesia for Treatment of Adults With Fractures and Dislocations in the Emergency Department
NCT07314450Pain, Procedural, Analgesia, Extremity Injury, Patient Satisfaction
Region Zealand
Observational
200
Holbæk, Køge, Odense
2025-07-29
Recruiting
Amgen
Phase 3
12,800
Aalborg, Aarhus N, Esbjerg, Gandrup, Herlev, Herning, Holbæk, Hvidovre
2025-07-25
Recruiting
Boehringer Ingelheim
Phase 3
4,200
Aabenraa, Copenhagen, Copenhagen NV, Copenhagen S, Herlev, Holbæk, Hvidovre, Roskilde
2025-05-20
Recruiting
AstraZeneca
Phase 3
5,000
Aalborg, Aarhus, Copenhagen E, Herlev, Herning, Holbæk, Kolding
2025-03-03
Recruiting
Glostrup University Hospital, Copenhagen
Not applicable
130
Glostrup Municipality, Holbæk
2024-12-09
By invitation
Effect of Access to Dietary Intervention in a Dialysis Unit
NCT06996405Dialysis, Diabetes, Nutritional Status, Diet Therapy
Zealand University Hospital
Not applicable
40
Holbæk, Næstved, Slagelse
2024-11-27
By invitation
Skeletal Maturation and Endocrine Health in Young Adults
NCT06509776Osteoporosis, Sarcopenia, Obesity, Cardiovascular Diseases
Holbaek Sygehus
Observational
2,000
Aalborg, Aarhus, Copenhagen, Frederiksberg, Holbæk, Hvidovre, Køge, Odense
2024-11-11
Active, closed
Continuous Glucose Monitoring in Dialysis Patients With Diabetes
NCT06641765Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 1, Continuous Glucose Monitoring, Haemodialysis
Bo Feldt-Rasmussen
Not applicable
96
Copenhagen, Herlev, Hillerød, Holbæk, Roskilde
2024-11-01
Recruiting
Herlev and Gentofte Hospital
Phase 4
17,200
Copenhagen, Herlev, Hillerød, Holbæk, Hvidovre, Køge, Nykøbing Falster, Roskilde
2024-10-10
Recruiting
What Influence Re-participation in the Danish Colorectal Screening Program.
NCT07353632Colonoscopy, Screening Colonscopy, Pain
Esbjerg Hospital - University Hospital of Southern Denmark
Observational
8,000
Aabenraa, Esbjerg, Grindsted, Gødstrup, Holbæk, Køge, Nykøbing Falster, Slagelse
2024-09-23
Active, closed
Novo Nordisk A/S
Phase 4
500
Aarhus, Gistrup, Holbæk
2024-09-17
Recruiting
CSL Behring
Phase 2/3
3,110
Aalborg, Herlev, Herning, Hillerød, Holbæk
2024-04-27
Active, closed
AstraZeneca
Phase 3
2,554
Aalborg, Aarhus, Copenhagen E, Esbjerg, Herlev, Herning, Holbæk
2024-03-29
Recruiting
Keeping it Simple Study (KISS)
NCT06297447Musculoskeletal Pain, Chronic Pain
Bettina Eiger
Not applicable
200
Holbæk, Køge, Solrød Strand
2024-03-11
Active, closed
Eli Lilly and Company
Phase 3
17,300
Aabenraa, Aarhus, Copenhagen, Esbjerg, Gandrup, Herlev, Holbæk, Vejle
2024-03-05
Recruiting
Bispebjerg Hospital
Not applicable
400
Herlev, Holbæk, Køge
2024-03-04
Active, closed
REWRITALIZE Your Recovery - Evaluation of a Creative Writing Group Intervention
NCT06251908Schizophreniform Disorders, Bipolar Disorder, Severe Depression, Ptsd
Amager Hospital
Not applicable
300
Rønne, Copenhagen, Hillerød, Holbæk, Vordingborg
2024-02-12
Active, closed
Novo Nordisk A/S
Phase 3
212
Aarhus, Gistrup, Holbæk
2023-07-07
Active, closed
Janssen Research & Development, LLC
Phase 3
20,284
Aarhus, Copenhagen S, Herlev, Herning, Holbæk, Hvidovre, Køge, Slagelse
2023-04-11
Active, closed
Novo Nordisk A/S
Phase 3
7,101
Herlev, Aarhus N, Holbæk, Svendborg, Herning, Hillerød, Kolding, Slagelse
2023-03-01
Recruiting
INfluenza VaccInation To Mitigate typE 1 Diabetes
NCT05585983Diabetes Mellitus, Type 1
Aarhus University Hospital
Phase 4
100
Aalborg, Aarhus, Copenhagen, Herning, Holbæk, Nykøbing Falster, Randers, Roskilde
2022-12-14
Active, closed
Amgen
Phase 3
7,297
Aalborg, Aarhus N, Copenhagen O, Esbjerg, Gandrup, Herlev, Herning, Holbæk
2022-12-14
Recruiting
Scandinavian Humeral Diaphyseal Fracture Trial
NCT04574336Fracture Humerus of Shaft
Kolding Sygehus
Not applicable
287
Aabenraa, Aarhus, Copenhagen, Esbjerg, Farsø, Gentofte Municipality, Hillerød, Holbæk
2022-04-04
Recruiting
Oral Health and Adverse Pregnancy Complications
NCT06110143Periodontal Diseases, Pregnancy Complications, Pregnancy Preterm, Gestational Diabetes
University Hospital Bispebjerg and Frederiksberg
Not applicable
600
Holbæk, Nykøbing Falster
2021-11-13
Recruiting
Diabetic Nephropathy in People With Diabetes. Prevalence and Predictive Factors
NCT04916132Chronic Kidney Diseases, Albuminuria, Diabetic Kidney Disease, Diabetic Nephropathies
Herlev Hospital
Observational
300
Skejby, Copenhagen, Hillerød, Holbæk, Køge, Nykøbing Falster, Roskilde, Slagelse
2021-08-10
Recruiting
The Danish Warfarin-Dialysis Study - Safety and Efficacy of Warfarin in Patients With Atrial Fibrillation on Dialysis
NCT03862859Atrial Fibrillation and Flutter, Stroke, Major Bleed, End-stage Renal Disease
DrugWarfarin
Nicholas Carlson
Phase 4
718
Herlev, Hillerød, Aalborg, Aarhus, Copenhagen, Esbjerg, Holbæk, Holstebro
2019-10-09
Recruiting
A Prospective Danish National Registry of PTRA in Patients With Renovascular Hypertension
NCT02770066Renal Artery Obstruction, Hypertension, Renovascular, Cardiovascular Diseases, Kidney Diseases
University of Aarhus
Observational
160
Aalborg, Aarhus N, Glostrup Municipality, Holbæk, Odense C
2015-01-01
Rows per page Showing 1–36 of 36
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Danish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 16 October 2026. https://priyalifescience.com/clinical-trials-denmark/city/holb-k

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Denmark and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,469 studies in total at the last sync on 16 Oct 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 36 of those studies with a site in Holbæk.

How many clinical trials are recruiting in Holbæk?

24 of the 36 studies on this page are recruiting new participants as of the 16 Oct 2026, 03:17 UTC sync. A further 1 have not yet opened recruitment, 9 are active but closed to new participants, and 2 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Holbæk), 36 studies
PhaseStudiesRecruitingShare
Phase 315941.7%
Not applicable8522.2%
Phase 46516.7%
Observational5413.9%
Phase 2102.8%
Phase 2/3112.8%

Most active sponsors

Lead sponsors with the most studies (Holbæk)
Lead sponsorStudiesRecruiting
AstraZeneca54
Novo Nordisk A/S52
Amgen21
Copenhagen Respiratory Research22
Aarhus University Hospital11
Alnylam Pharmaceuticals11
Amager Hospital10
Bettina Eiger11
Bispebjerg Hospital11
Bo Feldt-Rasmussen10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.